QIAGEN QIAstat-Dx syndromic testing instrument

Monday, 01 April, 2019 | Supplied by: QIAGEN Pty Ltd


..jpg

In the near-patient clinical lab, acute conditions like respiratory disease require immediate intervention. Correct identification of the causative pathogen is key to selecting the right treatment, but many respiratory pathogens cause similar symptoms. This makes it difficult for scientists to know which one they’re up against.

Multiplex syndromic testing rapidly and simultaneously surveys a large number of pathogens, giving users the answers they need when they need them.

Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time. The TGA registered panels are available now in Australia.

For more information: https://qiastat-dx.com/row/are-you-ready-for-a-new-era-in-multiplex-syndromic-testing/.

Online: www.qiagen.com
Phone: 03 9840 9800
Related Products

AdipoGen Life Sciences APRIL ELISA Kit and BAFF ELISA Kit

AdipoGen Life Sciences has released ELISA kits for the specific quantitative determination of the...

Cayman Chemical Bile Acid Nuclear Receptor FXR (NR1H4) Reporter Assay Kit

Cayman Chemical's Bile Acid Nuclear Receptor FXR (NR1H4) Reporter Assay Kit is a cell-based...

Thermo Fisher Scientific Applied Biosystems PureQuant Assays

Applied Biosystems PureQuant Assays, from Thermo Fisher Scientific, are a family of assays that...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd